SPDR S&P Biotech ETF (XBI) sees strength amid more deal headlines
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) sees strength amid more deal headlines. Today it's PFE/GBT. The sector ETF is up 1.7%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Accenture plc (ACN) Reiterated at Buy by Stifel as In-Line Q4 Results Expected
- Saudi Arabia shuts East-West Pipeline after attacks
- QatarEnergy trading seeks 2-3M tons per annum of LNG through 2031 as Ras Laffan repairs are seen raking 3-5 years - Reuters
Create E-mail Alert Related Categories
ETFs, Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
